Solid Malignancies
Oncology·MeSH: Hematologic Neoplasms
21 drugs in development·8 companies·4 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 2(2)
Phase 1(7)
Preclinical(2)
Early Phase 1(1)
| Drug | Company |
|---|---|
| 177lu-im-3050 | Immunome Inc. (IMNM) |
Phase 1/Phase 2(3)
Phase 2/Phase 3(2)
Phase 4(1)
| Drug | Company |
|---|---|
| BMS-986523 | BRISTOL MYERS SQUIBB CO (BMY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Solid Malignancies?
BioSniper tracks 21 drugs in development for Solid Malignancies across 8 companies.
How many clinical trials target Solid Malignancies?
There are 4 clinical trials targeting Solid Malignancies tracked by BioSniper.
Deep-dive into Solid Malignancies
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis